What is LGNDZ stock price today?

LGNDZ (Ligand Pharmaceuticals Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LGNDZ stock going up or down today?

LGNDZ stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LGNDZ stock now?

The decision to buy LGNDZ depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LGNDZ a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LGNDZ based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LGNDZ stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LGNDZ is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LGNDZ's P/E ratio?

P/E ratio data for LGNDZ will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LGNDZ's market cap?

Visit our dashboard for LGNDZ's current market capitalization and other key metrics.

What is LGNDZ's price to book ratio?

Price-to-book ratio for LGNDZ is available on our dashboard along with other valuation metrics.

Does LGNDZ pay dividends?

LGNDZ does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LGNDZ's dividend yield?

LGNDZ does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LGNDZ stock a good long-term investment?

LGNDZ's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LGNDZ's revenue growth rate?

LGNDZ has shown revenue growth of 0.4% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, LGNDZ is profitable with a profit margin of 0.5%. This indicates the company generates 0.5 cents of profit for every dollar of revenue.

What are the risks of investing in LGNDZ?

Key risks for LGNDZ include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LGNDZ compare to its competitors?

Compare LGNDZ to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LGNDZ's performance and positioning.

What is LGNDZ's stock price target for 2026?

Our AI model provides price targets for LGNDZ based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LGNDZ?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LGNDZ. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LGNDZ's next earnings report?

LGNDZ reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LGNDZ - Ligand Pharmaceuticals Inc

NYSE

$0.00

$-0.00 (-5.88%)

About Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

LGNDZ Key Statistics

Market Cap

$0.00M

Revenue Growth

+0.4%

Profit Margin

0.5%

Employees

How LGNDZ Compares to Peers

LGNDZ has the highest profit margins in its peer group

LGNDZ has the fastest revenue growth among competitors

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

N/A

of 1

Company	Market Cap	P/E	Growth	Margin	Compare
LGNDZ(This stock)	$0.00	N/A	0%	0.5%	-
AMZNAmazon Com	$2.75T	35.6	0%	0.1%	vs AMZN

Ligand Pharmaceuticals Inc Company Information

Headquarters: 555 Heritage Drive, Jupiter, FL, United States, 33458, undefined
Website: www.ligand.com

About Ligand Pharmaceuticals Inc

LGNDZ Key Statistics

How LGNDZ Compares to Peers

Ligand Pharmaceuticals Inc Company Information

Upcoming Events for LGNDZ